I belief HIT owners ought to be getting nervous.
HIT owners have long liked a blanketed status and uncritical accommodation relative to other scientific device industries and pharma, with contracts that gag scientific specialists from disclosing defects that may also simply deceive and cause affected consumer harm, and that absolve the HIT owners themselves from liability. HIT is, in fact, a virtual scientific device that other predominant countries (e.g., in the EU) are already moving towards regulating in a technique similar to physical scientific devices.
The HIT dealer "special status" may be coming to a close, and proper proper here's a sign in that direction:
Wall Street Journal
August 12, 2009
FDA Medical-Device Regulator Resigns
By ALICIA MUNDY
WASHINGTON -- The Food and Drug Administration's most interesting medical-device regulator said Tuesday he is resigning.
The departure follows internal dissent over device-approval decisions that the regulator's critics said have been too exceptional to industry.
Daniel Schultz said his move comes "by mutual agreement" with FDA Commissioner Margaret Hamburg, who took office in May. [In other words, he was asked to go away - ed.]
An FDA spokesman said Dr. Schultz's choice got proper the following as the quit finish impact of talks with Dr. Hamburg, and had nothing to do with any actual challenge related to a device's approval process.
Drug Chief at the FDA Is Accused of Conflict
Dr. Schultz has worked at the FDA's Center for Devices and Radiological Health for 15 years and led it for the past five years.
Sen. Chuck Grassley (R., Iowa) held hearings five hundred years ago on Dr. Schultz's approval of a nerve stimulation device to treat depression, approval that got proper the following over the objections of a number of FDA doctors. Mr. Grassley complained at the time that science was being neglected in hope of industry. Dr. Schultz said his choice was based commonly on sound scientific data.
In March, Sen. Grassley opened an examine proper suitable into a knee-surgery device made by means of ReGen Biologics Inc., after The Wall Street Journal reported that Dr. Schultz general it over the objections of lots of FDA scientists and reviewers.
FDA Deputy Commissioner Joshua Sharfstein said in May that the agency ought to re-examine the approval process for the ReGen knee device to see if real procedures have been followed.
A workforce of nine device division staff wrote to the House Energy and Commerce Committee last October to complain that the division's leaders had general sets despite formal safety and efficacy points raised by means of FDA. They also alleged a number of scientists who objected to the decisions faced retaliation from leaders of the device division. [This sounds quite a bit simply identical to the global of properly being IT, the location whistleblowers on HIT safety may find themselves persona non grata - ed.] The FDA at the time declined to comment.
These are serious matters, and under the Obama administration I see a replacement as being far masses so much less exceptional and quite a bit masses so much less doubtless to treat both physical and virtual (i.e., HIT) scientific device makers.
The irony is that Medical Informatics specialists akin to myself and like minded colleagues have offered help to the HIT and scientific device owners and buyers regularly over the years to boost finest of their item in a substantive, scientific informatics-driven manner, and therefore scale again the chances for strong government regulation.
We have been regularly ignored, or instructed "we don't hope scientific informatics here" or equivalent, or patronized (e.g., being instructed by means of a number of corporate bureaucrat out of a Dilbert comic strip that "you don't have enough experience" or the an identical in buzzword compliant corporate mumbo-jumbo. See example letter below.)
Seeing increasing risks to patients from cavalier, trade IT-based ways to HIT design, development, implementation and lifecycle, I and like minded colleagues are in fact using our talents to bolster the case for more robust government regulation of HIT. We in fact experience it's properly past the degree of helping this industry, and holding patients, from within.
If I have been an HIT dealer used to generous accommodation of sloppy item and lack of regulatory oversight, I'd be re-examining my assumptions in regards to the HIT business.
You are now reading the articleFDA Medical Device Regulator Resigns: Should Health IT Vendors Be Nervous? with the link address http://www.befluster.me/2018/10/fda-medical-device-regulator-resigns.html